Free tool
FAERS Monitor: Thallous Chloride Tl 201
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018150 or its brand name (Thallous Chloride Tl 201, Thallous Chloride Tl-201). Reports on generic versions are filed under their own applications.
Reports
51
Serious
36
71% of reports
Hospitalization
8
Death reported
7
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- tremor8
- dizziness7
- dyspnoea7
- chills6
- hyperhidrosis6
- asthenia5
- hepatitis b4
- nausea4
- blood pressure decreased3
- bradycardia3
- chest pain3
- hypotension3
- pyrexia3
- rash3
- cough2
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2005 | 5 |
| 2007 | 1 |
| 2008 | 9 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 6 |
| 2019 | 2 |
| 2020 | 21 |
| 2021 | 1 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,108 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| hepatitis bSignal | 4 | 273.9 | 106.9 | 832 |
| bradycardiaSignal | 3 | 23.3 | 7.8 | 44 |
| chillsSignal | 6 | 21.1 | 10.0 | 96 |
| tremorSignal | 8 | 19.9 | 10.5 | 126 |
| hyperhidrosisSignal | 6 | 19.2 | 9.1 | 87 |
| blood pressure decreasedSignal | 3 | 18.6 | 6.2 | 34 |
| chest painSignal | 3 | 6.7 | 2.2 | 9 |
| hypotensionSignal | 3 | 6.2 | 2.1 | 8 |
| dizzinessSignal | 7 | 5.8 | 2.9 | 24 |
| astheniaSignal | 5 | 5.5 | 2.4 | 14 |
| dyspnoeaSignal | 7 | 5.1 | 2.6 | 20 |
| pyrexia | 3 | 3.6 | 1.2 | 3 |
| cough | 2 | 2.9 | 0.8 | 1 |
| rash | 3 | 2.8 | 0.9 | 2 |
| nausea | 4 | 2.1 | 0.8 | 1 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.